IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinoma

Autor: Cui, Chuanliang, Li, Juan, Yang, Yue, Si, Lu, Chi, Zhihong, Mao, Lili, Wang, Xuan, Tang, Bixia, Yan, Xieqiao, Li, Siming, Zhou, Li, Wei, Xiaoting, Shen, Yuping, Guo, Qun, Zheng, Shirui, Guo, Jun, Lian, Bin
Zdroj: In The Innovation 1 July 2024 5(4)
Databáze: ScienceDirect